Follow
In-Vitro Diagnostic Testing
IVD, or in-vitro diagnostics are tests done on sample like blood or tissue that were taken from the human body. They can be used to detect diseases or other conditions and to monitor a person's overall health to help cure, treat, or prevent diseases.
-
APR 21, 2021 | 7:30 AM
The SARS-CoV-2 pandemic is challenging our health care systems and has profoundly impacted our society. Due to the poor global public health response, SARS-CoV-2 has developed many variants....Speaker: Eric Allen, MBA, M. Eng. Bioengineering , Michael Oberholzer, PhDPresented at: Genetics Week Virtual Event Series 2021
APR 14, 2021 | 12:00 AM
Developing an in vitro diagnostic device is often a complex and demanding process. Doing so in the midst of a pandemic and the IVD global supply chain stretched like never before, with proje...MAR 30, 2021 | 11:00 AM
Date: March 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) As the world continues to have a need for COVID-19 testing, BD offers a reliable rapid antigen COVID-19 testing solution through the BD...OCT 27, 2020 | 6:00 AM
DATE: October 27th, 2020 TIME: 6:00am PT Bruker proudly introduces the latest member of the MALDI Biotyper® product family, the MALDI Biotyper sirius one. Bruker‘s newest sirius sy...OCT 08, 2020 | 6:00 AM
Every patient is different and so is every tumor! The term “personalized oncology” today is largely associated with sequencing approaches. Current publications proof more and mor...Speaker: Christian Regenbrecht, PhDPresented at: Cancer Research & Oncology Week Virtual Event Series 2020
Sponsored By: Luminex - A DiaSorin CompanyOCT 07, 2020 | 12:00 PM
Cancer is a multifactorial disease, and its genesis and progression are extremely complex. The scope of precision oncology is rapidly expanding to address previously undruggable targets. The...Speaker: Dr. Ming LiuSEP 10, 2020 | 12:00 AM
Viruses are the causative agents of approximately 12% of human cancers. The most recently discovered herpesvirus, Kaposi’s sarcoma herpesvirus (KSHV) is known to cause three human canc...SEP 09, 2020 | 12:00 AM
Human chromosome 19q13.4 contains genes encoding killer-cell immunoglobulin-like receptors (KIR). The region has certain properties such as single nucleotide variation, structural variation,...SEP 08, 2020 | 11:00 PM
While viral fusion proteins are highly desirable for subunit vaccine generation, their inherent metastable nature complicates implementation and development. We have harnessed the structural...JUL 01, 2020 | 8:00 AM
DATE: July 1, 2020 TIME: 8:00 am PDT, 11:00 am EDT In late 2019, researchers identified the SARS-CoV-2 pathogen as the virus responsible for COVID-19. The virus spread rapidly throughout the...Speaker: Lauren Mikulski , Vijay Singh, PhD , Andrew Brooks, Ph.D.Sponsored By: Thermo Fisher ScientificJUN 17, 2020 | 1:30 PM
Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...Speaker: Joseph M. Beechem, PhD , Christopher E. Mason, PhD , Robert Schwartz, PhDJUN 17, 2020 | 12:00 PM
The spread of the SARS-COV-2 (COVID-19) pandemic is driving an urgent need for extensive testing, in order to quickly and accurately assess both who is infected, and who has been infected. I...Speaker: Klaus Hochleitner, PhD , Brendan O'Farrell, PhD , Darren Rowles , David Wilson , Lee JenkinsMAY 20, 2020 | 12:00 AM
We describe a mass spectrometry (MS) analytical platform resulting from the novel integration of acoustic droplet ejection (ADE) technology, an open-port interface (OPI), and electrospray io...Speaker: Luke Ghislain, PhDAPR 03, 2020 | 9:00 AM
DATE: April 3, 2020 TIME: 9:00am PT, 12:00pm ET The BioGX SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from...FEB 26, 2020 | 1:30 PM
Whether you are performing killing assays, characterizing the tumor microenvironment, or investigating immunogenicity, primary cells are essential for the discovery of new therapeutics. Conc...Speaker: Josh Mahlios, PhDFEB 19, 2020 | 11:00 AM
DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...JAN 01, 2020 | 6:00 AM
Microphysiological systems (MPS), also known as organ-on-chips, are small scale in vitro cell cultures which mimic facets of tissue or organ level function. MPS frequently utilise primary hu...Speaker: Tomasz Kostrzewski, PhDPresented at: Drug Discovery & Development Virtual Event Series 2020
JAN 01, 2020 | 6:00 AM
The aim of the lecture is to give an insight into the use of 3D liver micro tissues (3D liMTs) in drug discovery and translational safety. In translational toxicology, 3D LiMTs have a high i...JAN 01, 2020 | 6:00 AM
The use of primary cells in vitro is compromised by the limited quantity of cells that can be isolated from one donor, a lack of or very restricted proliferation capacity (e.g. hepatocytes)...Speaker: Astrid Nörenberg, PhDPresented at: Drug Discovery & Development Virtual Event Series 2020
JAN 01, 2020 | 6:00 AM
Accurate DNA replication is essential to transmit the genetic information from one generation to another. However, replication is frequently challenged by barriers that originate from exogen...Speaker: Chames Kermi, PhD, PharmDPresented at: Drug Discovery & Development Virtual Event Series 2020
JAN 01, 2020 | 6:00 AM
“The poor translatability of early-stage preclinical models is a major setback in oncology drug development. Immortalized cell lines, that are extensively used in drug screens, undergo...JAN 01, 2020 | 6:00 AM
The liver plays a critical role in the metabolism and clearance of more than 70% of marketed drugs. Furthermore, toxicity to the liver is a major reason for preclinical and clinical drug fai...JAN 01, 2020 | 6:00 AM
With an increasing push to improve safety, efficacy, and efficiency throughout the drug development pipeline, researchers are evermore looking to improve the predictive capacity of their in...OCT 10, 2019 | 10:30 AM
Osteosarcoma (OS) is the most common bone tumor in pediatric and adolescent/young adult patients. Over the past three decades, significant improvements in the survival rates or therapeutic ap...Speaker: Troy McEachron, PhDPresented at: Cancer Research & Oncology Week Virtual Event Series 2019
Sponsored By: NanoString Technologies
APR 21, 2021 | 7:30 AM
The SARS-CoV-2 pandemic is challenging our health care systems and has profoundly impacted our society. Due to the poor global public health response, SARS-CoV-2 has developed many variants....
Speaker:
Eric Allen, MBA, M. Eng. Bioengineering
, Michael Oberholzer, PhD
Presented at: Genetics Week Virtual Event Series 2021
APR 14, 2021 | 12:00 AM
Developing an in vitro diagnostic device is often a complex and demanding process. Doing so in the midst of a pandemic and the IVD global supply chain stretched like never before, with proje...
MAR 30, 2021 | 11:00 AM
Date: March 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) As the world continues to have a need for COVID-19 testing, BD offers a reliable rapid antigen COVID-19 testing solution through the BD...
OCT 27, 2020 | 6:00 AM
DATE: October 27th, 2020 TIME: 6:00am PT Bruker proudly introduces the latest member of the MALDI Biotyper® product family, the MALDI Biotyper sirius one. Bruker‘s newest sirius sy...
OCT 08, 2020 | 6:00 AM
Every patient is different and so is every tumor! The term “personalized oncology” today is largely associated with sequencing approaches. Current publications proof more and mor...
Speaker:
Christian Regenbrecht, PhD
Presented at: Cancer Research & Oncology Week Virtual Event Series 2020
Sponsored By: Luminex - A DiaSorin Company
Sponsored By: Luminex - A DiaSorin Company
OCT 07, 2020 | 12:00 PM
Cancer is a multifactorial disease, and its genesis and progression are extremely complex. The scope of precision oncology is rapidly expanding to address previously undruggable targets. The...
Speaker:
Dr. Ming Liu
SEP 10, 2020 | 12:00 AM
Viruses are the causative agents of approximately 12% of human cancers. The most recently discovered herpesvirus, Kaposi’s sarcoma herpesvirus (KSHV) is known to cause three human canc...
SEP 09, 2020 | 12:00 AM
Human chromosome 19q13.4 contains genes encoding killer-cell immunoglobulin-like receptors (KIR). The region has certain properties such as single nucleotide variation, structural variation,...
SEP 08, 2020 | 11:00 PM
While viral fusion proteins are highly desirable for subunit vaccine generation, their inherent metastable nature complicates implementation and development. We have harnessed the structural...
JUL 01, 2020 | 8:00 AM
DATE: July 1, 2020 TIME: 8:00 am PDT, 11:00 am EDT In late 2019, researchers identified the SARS-CoV-2 pathogen as the virus responsible for COVID-19. The virus spread rapidly throughout the...
Speaker:
Lauren Mikulski
, Vijay Singh, PhD
, Andrew Brooks, Ph.D.
Sponsored By: Thermo Fisher Scientific
JUN 17, 2020 | 1:30 PM
Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
Speaker:
Joseph M. Beechem, PhD
, Christopher E. Mason, PhD
, Robert Schwartz, PhD
JUN 17, 2020 | 12:00 PM
The spread of the SARS-COV-2 (COVID-19) pandemic is driving an urgent need for extensive testing, in order to quickly and accurately assess both who is infected, and who has been infected. I...
Speaker:
Klaus Hochleitner, PhD
, Brendan O'Farrell, PhD
, Darren Rowles
, David Wilson
, Lee Jenkins
MAY 20, 2020 | 12:00 AM
We describe a mass spectrometry (MS) analytical platform resulting from the novel integration of acoustic droplet ejection (ADE) technology, an open-port interface (OPI), and electrospray io...
Speaker:
Luke Ghislain, PhD
APR 03, 2020 | 9:00 AM
DATE: April 3, 2020 TIME: 9:00am PT, 12:00pm ET The BioGX SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from...
FEB 26, 2020 | 1:30 PM
Whether you are performing killing assays, characterizing the tumor microenvironment, or investigating immunogenicity, primary cells are essential for the discovery of new therapeutics. Conc...
Speaker:
Josh Mahlios, PhD
FEB 19, 2020 | 11:00 AM
DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
JAN 01, 2020 | 6:00 AM
Microphysiological systems (MPS), also known as organ-on-chips, are small scale in vitro cell cultures which mimic facets of tissue or organ level function. MPS frequently utilise primary hu...
Speaker:
Tomasz Kostrzewski, PhD
Presented at: Drug Discovery & Development Virtual Event Series 2020
JAN 01, 2020 | 6:00 AM
The aim of the lecture is to give an insight into the use of 3D liver micro tissues (3D liMTs) in drug discovery and translational safety. In translational toxicology, 3D LiMTs have a high i...
JAN 01, 2020 | 6:00 AM
The use of primary cells in vitro is compromised by the limited quantity of cells that can be isolated from one donor, a lack of or very restricted proliferation capacity (e.g. hepatocytes)...
Speaker:
Astrid Nörenberg, PhD
Presented at: Drug Discovery & Development Virtual Event Series 2020
JAN 01, 2020 | 6:00 AM
Accurate DNA replication is essential to transmit the genetic information from one generation to another. However, replication is frequently challenged by barriers that originate from exogen...
Speaker:
Chames Kermi, PhD, PharmD
Presented at: Drug Discovery & Development Virtual Event Series 2020
JAN 01, 2020 | 6:00 AM
“The poor translatability of early-stage preclinical models is a major setback in oncology drug development. Immortalized cell lines, that are extensively used in drug screens, undergo...
JAN 01, 2020 | 6:00 AM
The liver plays a critical role in the metabolism and clearance of more than 70% of marketed drugs. Furthermore, toxicity to the liver is a major reason for preclinical and clinical drug fai...
JAN 01, 2020 | 6:00 AM
With an increasing push to improve safety, efficacy, and efficiency throughout the drug development pipeline, researchers are evermore looking to improve the predictive capacity of their in...
OCT 10, 2019 | 10:30 AM
Osteosarcoma (OS) is the most common bone tumor in pediatric and adolescent/young adult patients. Over the past three decades, significant improvements in the survival rates or therapeutic ap...
Speaker:
Troy McEachron, PhD
Presented at: Cancer Research & Oncology Week Virtual Event Series 2019
Sponsored By: NanoString Technologies
Sponsored By: NanoString Technologies